V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Virology

• Publication date

  1992-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0042-6822(92)90444-TPMID 1546447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain

  1991cited by this paper
• The V3 Loops of the HIV-1 and HTV-2 Surface Glycoproteins Contain Proteolytic Cleavage Sites: A Possible Function in Viral Fusion?

  1991cited by this paper
• Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp!20 gene

  1991cited by this paper
• Alteration of HIV-1 Infectivity and Neutralization by a Single Amino Acid Replacement in the V3 Loop Domain

  1991cited by this paper
• Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene

  1991cited by this paper
• HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain

  1990cited by this paper
• Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.

  1990cited by this paper
• Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.

  1990cited by this paper
• Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding

  1990cited by this paper
• Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants

  1990cited by this paper
• Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.

  1990cited by this paper
• A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site.

  1990cited by this paper
• Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

  1989cited by this paper
• Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids.

  1989cited by this paper
• Involvement of tryptase‐related cellular protease(s) in human immunodeficiency virus type 1 infection

  1989cited by this paper
• Simple and Rapid Preparation of Samples for PCR

  1989cited by this paper
• Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120

  1989cited by this paper
• Functional interaction of constant and variable domains of human immunodeficiency virus type 1 gp120

  1989cited by this paper
• Antibodies from Human Immunodeficiency Virus-Infected Individuals Bind to a Short Amino Acid Sequence that Elicits Neutralizing Antibodies in Animals

  1989cited by this paper
• Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

  1988cited by this paper
• Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

  1988cited by this paper
• Human immunodeficiency virus infection of CD4‐bearing cells occurs by a pH‐independent mechanism.

  1988cited by this paper
• In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity

  1988cited by this paper
• Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

  1988cited by this paper
• Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines

  1988cited by this paper
• Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1

  1988cited by this paper
• Analysis and prediction of the different types of beta-turn in proteins.

  1988cited by this paper
• Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.

  1988cited by this paper
• Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4

  1988cited by this paper
• Characteristics of a Neutralizing Monoclonal Antibody to the HIV Envelope Glycoprotein

  1988cited by this paper
• Analysis and prediction of the different types of β-turn in proteins

  1988cited by this paper
• Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.

  1987cited by this paper
• pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.

  1987cited by this paper
• High-efficiency transformation of mammalian cells by plasmid DNA.

  1987cited by this paper
• Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.

  1987cited by this paper
• Complete Nucleotide Sequences of Functional Clones of the AIDS Virus

  1987cited by this paper
• The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

  1986cited by this paper
• Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.

  1986cited by this paper
• Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity

  1986cited by this paper
• Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein

  1986cited by this paper
• Complete nucleotide sequence of the AIDS virus, HTLV-III

  1985cited by this paper
• Oligonucleotide-Directed Mutagenesis: A Simple Method Using Two Oligonucleotide Primers and a Single-Stranded DNA Template

  1984cited by this paper
• The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

  1984cited by this paper
• T-lymphocyte T4 molecule behaves as the receptor for human retrovirus  LAV

  1984cited by this paper
• The entry into host cells of Sindbis virus, vesicular stomatitis virus and Sendai virus.

  1978cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper
• Leeuwenhoek Lecture: Virus-host cell interactions

  1958cited by this paper

• Adaptation of SIVmac to baboon primary cells results in complete absence of in vivo baboon infectivity

  2024cites this paper
• Unraveling clinical outcomes of long-term cART treatment in HIV-1 patients with or without the Brazilian GWGR motif in the V3 loop

  2024cites this paper
• Genetic Characteristics of the Env Regions in HIV-1-Infected Subjects in Baoding City, Hebei Province, China.

  2024cites this paper
• Glutathione in HIV-Associated Neurocognitive Disorders

  2024cites this paper
• Global Variability of V3 Loop Tetrapeptide Motif: a Concern for HIV-1 Neutralizing Antibodies-based Vaccine Design and Antiretroviral Therapy

  2021cites this paper
• gp120 Alters Its Conformation to Enhance Evasiveness and Infectivity

  2021cites this paper
• Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New Dendritic Cell-Targeting Vaccine Approach against HIV-1

  2021cites this paper
• Mouse Models Expresssing Precursors of Broadly Neutralizing Antibodies Against HIV

  2019cites this paper
• Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120

  2018cites this paper
• VIROLOGICAL AND IMMUNOLOGICAL FEATURES OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-l (HIV-l) PRE AND POST TREATMENT OF TUBERCULOSIS IN COINFECTED PATIENTS BY TSIGEREDA BIRU

  2017cites this paper
• Which Vaccination Strategies and Immune Responses are More Effective Against HIV Infections

  2016cites this paper
• HIV coreceptor tropism determination and mutational pattern identification

  2016cites this paper
• Characterization of Envelope-Specific Antibody Response Elicited by HIV-1 Vaccines: A Dissertation

  2015cites this paper
• Antibodies Targeting the Envelope of HIV-1

  2015cites this paper
• How can Improve DNA Vaccine Modalities as a Therapeutic Approach against HIV Infections

  2015cites this paper
• In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop

  2015cites this paper
• HIV-1 Envelope Glycoprotein 120 Induced Neuroinflammation Does Not Result in Neurocognitive Impairment in An in vivo Rat Model

  2015cites this paper
• Discovery of novel anti-HIV-1 agents based on a broadly neutralizing antibody against the envelope gp120 V3 loop: a computational study

  2014cites this paper
• Rabbit Anti-HIV-1 Monoclonal Antibodies Raised by Immunization Can Mimic the Antigen-Binding Modes of Antibodies Derived from HIV-1-Infected Humans

  2013cites this paper
• Dual-acting stapled peptides target both HIV-1 entry and assembly

  2013cites this paper
• Computer-Aided Search for Novel Anti-Hiv-1 Agents Presenting Peptidomimetics of Neutralizing Antibodies and Evaluation of their Potential Inhibitory Activity by Molecular Modeling

  2013cites this paper
• Computer-Aided Design of Novel HIV-1 Entry Inhibitors Based on Glycosphingolipids

  2013cites this paper
• HIV-1 V3 loop crown epitope-focused mimotope selection by patient serum from random phage display libraries: implications for the epitope structural features.

  2013cites this paper
• Genetic Variation in the HR Region of the env Gene of HIV: A Perspective for Resistance to HIV Fusion Inhibitors

  2011cites this paper
• Structural basis of the cross-reactivity of genetically related human anti-HIV-1 mAbs: implications for design of V3-based immunogens.

  2009cites this paper
• Design, synthesis and CD4 binding studies of a fluorescent analogue of a peptide that enhances HIV-1 infectivity.

  2009cites this paper
• HIV Type 1 Genetic Diversity in Moyale, Mandera, and Turkana Based on env-C2-V3 Sequences

  2008cites this paper
• Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages

  2007cites this paper
• Molecular Mechanism of HIV-1 Infection: Role of Viral and Host Determinants

  2006cites this paper
• Women infected with HIV type 1 Brazilian variant, subtype B (B'-GWGR motif) have slower progression to AIDS, compared with patients infected with subtype B (B-GPGR motif).

  2006cites this paper
• HIV-2 genetic evolution and viral dynamics

  2006cites this paper
• Caracterização Molecular e Biológica de Isolados do Subtipo C de HIV-1 Circulantes no Brasil

  2006influential citation
• Viral correlates of HIV-1 disease.

  2005cites this paper
• How does HIV-1 infect a susceptible human cell?: Current thinking.

  2003cites this paper
• The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C

  2003cites this paper
• Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades

  2002cites this paper
• HIV-1 Fitness : Implications for Drug Resistance , Disease Progression , and Global Epidemic Evolution

  2002cites this paper
• Virologic Risk Factors for Vertical Transmission of HIV Type 1 in Puerto Rico

  2002cites this paper
• Refocusing neutralizing antibody response by targeted dampening of an immunological epitope

  2001cites this paper
• Antigenicity and predefined specificities of the multi-epitope vaccine in candidate consisting of neutralizing epitope and mutated epitopes suggested a new way against HIV-1 mutation.

  2001cites this paper
• V3 induces in human normal cell populations an accelerated macrophage-mediated proliferation--apoptosis phenomenon of effector T cells when they respond to their cognate antigen.

  2001cites this paper
• Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization.

  2000cites this paper
• Deletion of the GPG Motif in the HIV Type 1 V3 Loop Does Not Abrogate Infection in All Cells

  2000cites this paper
• Peptide T blocks GP120/CCR5 chemokine receptor-mediated chemotaxis.

  1999cites this paper
• Modulation of HIV immune responses in natural infection and after genetic immunization

  1999cites this paper
• Carboxymethyl benzylamide sulfonate dextrans (CMDBS), a family of biospecific polymers endowed with numerous biological properties: a review.

  1999cites this paper
• Endogenous salivary inhibitors of human immunodeficiency virus.

  1999cites this paper
• Inhibitory Mechanism of the CXCR4 Antagonist T22 against Human Immunodeficiency Virus Type 1 Infection

  1999cites this paper
• Inhibitory Mechanism of the CXCR4 Antagonist T22 against Human Immunodeficiency Virus Type 1 Infection

  1999cites this paper
• Genetic Analysis of Human Immunodeficiency Virus Type 1 Strains in Kenya: A Comparison Using Phylogenetic Analysis and a Combinatorial Melting Assay

  1999cites this paper
• One-parameter discrete model of the genetic diversity.

  1998cites this paper
• V3 sequence diversity of HIV-1 subtype E in infected mothers and their infants.

  1998cites this paper
• Biological and conformational studies on analogues of a synthetic peptide enhancing HIV‐1 infection

  1998cites this paper
• High frequency of the GWG (Pro Trp) envelope variant of HIV-1 in Southeast Brazil.

  1998cites this paper
• Study of the V3 Loop as a Target Epitope for Antibodies Involved in the Neutralization of Primary Isolates versus T-Cell-Line-Adapted Strains of Human Immunodeficiency Virus Type 1

  1998cites this paper
• Determinants of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Activation by Soluble CD4 and Monoclonal Antibodies

  1998cites this paper
• Identification of a CD36-related Thrombospondin 1–binding Domain in HIV-1 Envelope Glycoprotein gp120: Relationship to HIV-1–specific Inhibitory Factors in Human Saliva

  1998cites this paper
• HIV Type 1 V3 Peptide Constructs Act Differently on HIV Type 1 Infection of Peripheral Blood Lymphocytes and Macrophages

  1997cites this paper
• Investigations using photo affinity labeled analogues confirm the binding between sCD4 and the PND of HIV-1, MN.

  1997cites this paper
• Antiviral activity of derivatized dextrans on HIV-1 infection of primary macrophages and blood lymphocytes.

  1997cites this paper
• Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1

  1997cites this paper
• Variability analysis of HIV-1 gp120 V3 region: I. Point estimators for the amino acid distribution characteristics.

  1997cites this paper
• Mutations of the HIV Type 1 V3 Loop under Selection Pressure with Neutralizing Monoclonal Antibody NM-01

  1997cites this paper
• Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope.

  1997cites this paper
• Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion

  1997cites this paper
• Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin)

  1997cites this paper
• Isolation and Characterization of Two Divergent Infectious Molecular Clones of HIV Type 1 Longitudinally Obtained from a Seropositive Patient by a Progressive Amplification Procedure

  1997cites this paper
• HIV Type 1 V3 Loop Sequences Derived from Peripheral Blood of Transmitting Mothers, Their Infants, and Nontransmitting Mothers Differ in Their Crown Octapeptide Motifs

  1997cites this paper
• The V1/V2 Region of Human Immunodeficiency Virus Type 1 Modulates the Sensitivity to Neutralization by Soluble CD4 and Cellular Tropism

  1997cites this paper
• Sculpted immunogens; B-cell epitope optimization using constrained secondary structure libraries.

  1996cites this paper
• The formulation and refinement of a polymerase chain reaction (PCR) assay for early diagnosis of paediatric HIV infection and genetic analysis of variants involved in vertical transmission of HIV-1

  1996cites this paper
• Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases.

  1996cites this paper
• Sequence Analysis of the V3 Loop in Brain and Spleen of Patients with HIV Encephalitis

  1996cites this paper
• Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells

  1996cites this paper
• Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants

  1996cites this paper
• Peptide secondary structure mimetics: applications to vaccines and pharmaceuticals.

  1996cites this paper
• The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection

  1996cites this paper
• Identification of the Paired Basic Convertases Implicated in HIV gp160 Processing Based on in Vitro Assays and Expression in CD4+ Cell Lines*

  1996cites this paper
• HIV‐1 Infection of the brain: Which pathogenic mechanisms are relevant for tissue damage?

  1995cites this paper
• Genetically Engineered HIV Type 1 Peptides as Tools for the Determination of Anti-V3 Loop Antibody Titers in Sera from HIV Type 1-Infected Patients

  1995cites this paper
• Epitope mapping of anti-HIV and anti-HCV monoclonal antibodies and characterization of epitope mimics using a filamentous phage peptide library.

  1995cites this paper
• The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection

  1995cites this paper
• V3 sequences in primary HIV-1 infection.

  1995cites this paper
• Single Basic Amino Acid Substitutions at Position 302 or 320 in the V3 Domain of HIV Type 1 Are Not Sufficient to Alter the Antiviral Activity of Dextran Sulfate and Heparin

  1995cites this paper
• Virus receptors: implications for pathogenesis and the design of antiviral agents

  1995cites this paper
• Efficient purification and rigorous characterisation of a recombinant gp120 for HIV vaccine studies.

  1995cites this paper
• Identification of V3 mutations that can compensate for inactivating mutations in C4 of simian immunodeficiency virus.

  1995cites this paper
• Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection.

  1995cites this paper
• Molecular Characterization of Human Immunodeficiency Virus Type 1 Isolates from Venezuela

  1995cites this paper
• Maintenance of Syncytium-Inducing Phenotype of HIV Type 1 Is Associated with Positively Charged Residues in the HIV Type 1 gp120 V2 Domain without Fixed Positions, Elongation, or Relocated N-Linked Glycosylation Sites

  1995cites this paper
• Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization

  1994cites this paper
• Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum

  1994cites this paper
• Conformational rearrangements required of the V3 loop of HIV‐1 gp120 for proteolytic cleavage and infection

  1994cites this paper
• Genetic and Antigenic Variability of HIV Type 1 in Brazil

  1994cites this paper
• Crystal structure of the principal neutralization site of HIV-1.

  1994cites this paper
• HIV Type 1 Infection of CD4+ T Cells Depends Critically on Basic Amino Acid Residues in the V3 Domain of Envelope Glycoprotein 120

  1994cites this paper
• Effect of a single amino acid substitution in the V3 domain of the human immunodeficiency virus type 1: generation of revertant viruses to overcome defects in infectivity in specific cell types

  1994cites this paper
• Clinical Factors Associated with Progression to AIDS in the Italian Cohort of HIV-Positive Hemophiliacs

  1994cites this paper
• Differential regulation of cellular tropism and sensitivity to soluble CD4 neutralization by the envelope gp120 of human immunodeficiency virus type 1

  1994cites this paper
• Pathogenesis of human immunodeficiency virus infection

  1993cites this paper